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Oxidative stress is a major source of chromosome single-strand breaks (SSBs), and the repair of these
lesions is retarded in neurodegenerative disease. The rate of the repair of oxidative SSBs is accelerated by
XRCC1, a scaffold protein that is essential for embryonic viability and that interacts with multiple DNA repair
proteins. However, the relative importance of the interactions mediated by XRCC1 during oxidative stress in
vivo is unknown. We show that mutations that disrupt the XRCC1 interaction with DNA polymerase  or DNA
ligase III fail to slow SSB repair in proliferating CHO cells following oxidative stress. In contrast, mutation of
the domain that interacts with polynucleotide kinase/phosphatase (PNK) and Aprataxin retards repair, and
truncated XRCC1 encoding this domain fully supports this process. Importantly, the impact of mutating the
protein domain in XRCC1 that binds these end-processing factors is circumvented by the overexpression of
wild-type PNK but not by the overexpression of PNK harboring a mutated DNA 3-phosphatase domain. These
data suggest that DNA 3-phosphatase activity is critical for rapid rates of chromosomal SSB repair following
oxidative stress, and that the XRCC1-PNK interaction ensures that this activity is not rate limiting in vivo.
Oxidative stress can have a major influence on genome in-
tegrity and cell survival and is an etiological factor in a number
of neurological human diseases. Of these, several are associ-
ated with defects in the repair of DNA damage, including
xeroderma pigmentosum (XP), ataxia telangiecatsia (A-T),
ataxia oculomotor apraxia 1 (AOA1), and spinocerebellar
ataxia with axonal neuropathy 1 (SCAN1) (1, 28, 34, 37). The
neuropathology evident in XP most likely reflects an inability
to repair one or more single-strand oxidative adducts by nu-
cleotide excision repair. In contrast, A-T is associated with
cellular defects in the repair of DNA double-strand breaks
(DSBs) and AOA1 and SCAN1 with defects in the repair of
DNA single-strand breaks (SSBs). SSBs are the commonest
DNA lesions arising in cells, and if they are not rapidly re-
paired they can inhibit transcription and/or generate replica-
tion-associated DSBs (3, 26, 59, 60). The repair of oxidative
SSBs involves DNA damage detection by PARP-1 followed by
recruitment of the enzymes required for subsequent steps of
the repair process, which include DNA end processing, DNA
gap filling, and DNA ligation (9, 19). Many of the enzymes
implicated in these steps interact physically with XRCC1, in-
cluding DNA polynucleotide kinase (PNK) (54), Aprataxin
(APTX) (13, 14, 18, 31, 44), DNA polymerase  (Pol ) (10,
27), and DNA ligase III (Lig3) (11, 12). This has prompted
the hypothesis that XRCC1 is a scaffold protein that recruits,
stabilizes, and/or stimulates SSB repair (SSBR) enzymes at
chromosomal SSBs, thereby accelerating the overall process
(8, 9). While in vitro analyses generally are consistent with this
idea, including the observation that XRCC1 mutation (50, 58),
deletion (49), or depletion (6) retards the rate of chromosomal
SSBR by approximately fivefold following DNA oxidation or
DNA base damage, the relative importance of the protein-
protein interactions mediated by XRCC1 for SSBR is unclear.
Here, we have addressed the importance of the protein-
protein interactions mediated by XRCC1 during the repair of
oxidative SSBs. To do this, we have employed isogenic XRCC1
mutant CHO cells expressing recombinant derivatives of
XRCC1 in which specific protein-protein interaction domains
are mutated. We find that whereas the interactions between
XRCC1 and either Pol  or Lig3 are dispensable for rapid
rates of chromosomal SSBR in asynchronous populations of
CHO cells following oxidative stress, SSBR rates are markedly
slowed in cells expressing XRCC1 that cannot interact with
PNK. Importantly, we show that the overexpression of wild-
type recombinant PNK, but not 3-phosphatase-dead PNK, can
override the requirement for PNK interaction with XRCC1 for
rapid rates of SSBR following oxidative stress. These data
indicate that DNA 3-phosphatase activity is critical for rapid
rates of chromosomal SSBR following oxidative stress, and
that the XRCC1 interaction with PNK prevents this activity
from becoming rate limiting.
MATERIALS AND METHODS
DNA constructs. pCD2E-XHF67A, pCD2E-XHS485A,T488A, and pCD2E-
XHS518A.T519A,T523A were created by the site-directed mutagenesis of the XRCC1
open reading frame (ORF) in pCD2E-XH (12) using a QuikChange mutagenesis
kit (Stratagene) and the appropriate primers. pCD2E and pCD2E-XHCKM have
been described previously (30, 46). To create pCD2E-XHS408A,S409A,S410A, a
KpnI fragment of wild-type XRCC1 cDNA from pCD2E-XH was replaced with
the corresponding fragment in pET16B-XHS408A,S409A,S410A (Richard Taylor,
unpublished data). To create pAS-XRCC1F67A, a CelII-BlnI fragment of XRCC1
from pAS-XH was replaced with the corresponding fragment from pCD2E-
XHF67A. To create pCD2E-PNKD171N, the PNK ORF in pCD2E-PNK (30) was
mutated by site-directed mutagenesis as described above. pCD2E-HX161-533
encoding His-XRCC1161-533 was created by PCR amplification, insertion into
pCR2.1-TOPO (Invitrogen), and subcloning into the EcoRI sites of pCD2E.
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Cell lines. The XRCC1 mutant CHO cell line EM9 and derivatives were
maintained as monolayers in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (vol/vol) fetal calf serum, 100 U/ml penicillin, 2 mM
glutamine, and 100 g/ml streptomycin. Expression constructs were introduced
into EM9 cells by calcium phosphate coprecipitation (EM9-XHF67A) or by
Genejuice (Novagen) transfection (EM9-XHCKM, EM9-XHS408A,S409A,S410A,
EM9-XHS485A,T488A, and EM9-XHS518A,T519A,T523A). Stable cell lines were pre-
pared by the selection of transfected cells with 1.5 mg/ml G418 (Gibco-Invitro-
gen) for 7 to 10 days.
Antibodies and immunoblotting. Cells were lysed in sodium dodecyl sulfate
(SDS) loading buffer at 90°C, and whole-cell extracts from 5  104 to 2.5  105
cells were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE).
Proteins were transferred to nitrocellulose and immunoblotted with anti-
XRCC1 monoclonal (clone 33.2.5), anti-XRCC1 polyclonal (SK3188), anti-
PNK (SK3195), anti-Lig3 polyclonal (TL25), anti-Pol polyclonal (a kind
gift from Grigory Dianov), or anti--actin monoclonal antibody (Sigma).
Yeast two-hybrid analyses. Saccharomyces cerevisiae Y190 cells were trans-
formed with the indicated pAS and pACT constructs, and transformants were
selected on yeast minimal medium plates (glucose plus yeast nitrogen base
without amino acids) supplemented with adenine and histidine. Pooled popula-
tions of transformants were streaked onto minimal medium supplemented with
either adenine and histidine for -galactosidase colony-lift filter assays or ade-
nine and 25 mM 3-amino-1,2,4-triazole for the analysis of histidine prototrophy.
Affinity purification of histidine-tagged XRCC1 protein complexes from CHO
cells. For the analysis of the XRCC1-Pol  interaction, whole-cell extract was
prepared from a confluent flask (T75) or plate (15 cm) of EM9-XH, EM9-
XHF67A, or EM9-V cells by resuspension in lysis buffer (25 mM HEPES, pH 8.0,
325 mM sodium chloride, 0.5% Triton X-100, 10% glycerol, 1 mM dithiothreitol
[DTT], 25 mM imidazole, 1/100 dilution of mammalian protease inhibitor cock-
tail [Sigma]) at a density of 6  106 cells/ml and incubated on ice for 15 min.
High-molecular-weight DNA was sheered by passage through a narrow-gauge
needle, and extracts were clarified by centrifugation (8,832  g) for 10 min at
2°C. For the analysis of the XRCC1-PNK interaction, EM9 cells were tran-
siently transfected with 8 g/dish each of pCD2E-PNK and either pCD2E-XH,
pCD2E-XHCKM, pCD2E-XHS408A,S409A,S410A, pCD2E-XHS485A,T488A, pCD2E-
XHS518A,T519A,T523A, or empty pCD2E using Genejuice (Novagen). Twenty-four
hours later, transiently transfected cell populations were selected in medium
containing 1.5 mg/ml G418 for 4 days. Cells (5  106) were harvested, washed,
and resuspended in 0.3 ml lysis buffer (25 mM HEPES, pH 8.0, 325 mM sodium
chloride, 10% glycerol, 1 mM DTT, 25 mM imidazole, 1/100 dilution of mam-
malian protease inhibitor cocktail [Sigma]) and sonicated (five 30-s pulses at high
power using a Biorupter sonicator). XRCC1-His complexes then were purified
from the clarified extract by metal-chelate affinity chromatography. Briefly, cell
extract (0.3 to 1 ml) was incubated with 0.25 to 0.5 ml nickel-nitrilotriacetic
acid-agarose (Qiagen) for 20 min on ice with frequent mixing. The resulting
suspension was added to a disposable 5-ml chromatography column (Polyprep;
Bio-Rad), and the flow rate was adjusted to 0.5 ml/min. The column was
washed (twice with 5 ml) with lysis buffer and then 5 ml of elution buffer (lysis
buffer containing 250 mM imidazole), and 0.5-ml fractions were collected.
Clonogenic survival assays. For survival assays, five hundred cells were plated
in 10-cm dishes in duplicate and incubated for 4 h at 37°C. Cells were rinsed with
phosphate-buffered saline (PBS) (twice) and either mock treated or treated with
H2O2 (diluted in PBS at the appropriate concentration immediately prior to use)
for 15 min at room temperature or with MMS (diluted in complete medium at
the appropriate concentration immediately prior to use) for 15 min at 37°C.
After treatment, cells were washed twice with PBS and incubated for 10 to 14
days in drug-free medium at 37°C to allow the formation of macroscopic colo-
nies. Colonies were fixed in ethanol (95%) and stained with 1% methylene
blue–70% ethanol. Colonies of greater than 50 cells were counted, and the
survival (as a percentage) was calculated using the equation 100  [mean colony
number (treated plate)/mean colony number (untreated plate)].
Alkaline single-cell agarose-gel electrophoresis (alkaline comet assay). To
examine EM9-XHF67A and its associated controls by alkaline comet assay, 2 
105 cells were plated in 3.5-cm culture dishes in complete medium and incubated
for 16 to 18 h at 37°C prior to mock treatment or treatment with 0.15 to 0.2 mM
H2O2 in PBS for 10 to 20 min on ice. For other cell lines, subconfluent mono-
layers were trypsinized and diluted to 4  105 cells/ml immediately prior to
treatment with H2O2 as described above. For exposure with gamma rays, cells
were treated in suspension (4  105 cells/ml) in complete medium. After treat-
ment with MMS, H2O2, or gamma irradiation (20 Gy), cells were washed once in
ice-cold PBS and incubated in fresh drug-free medium for the desired repair
period. Adherent cells were harvested in ice-cold PBS by scraping (1 ml/3.5-cm
plate), and 0.2 ml of the cell suspension was analyzed by alkaline comet assay as
previously described (7). For cells treated in suspension, 1-ml aliquots (4  105
cells) were analyzed as described above. For transient-transfection experiments,
EM9 cells were transiently cotransfected in 10-cm dishes with 8 g/dish of either
pCD2E-XH, pCD2E-XHS518A,T519A,T523A, or empty pCD2E and additionally
with 24 g/dish of either pCD2E-PNK, pCD2E-PNKD171N, or empty pCD2E
using Genejuice (Novagen). Twenty-four hours later cells were selected in me-
dium containing 1.5 mg/ml G418 for 4 days and then H2O2 treated or not treated
as described above.
RESULTS
XRCC1 interacts with polypeptide components of each of
the three core stages of DNA processing during SSBR (Fig.
1A). However, the relative importance of these interactions for
the repair of oxidative SSBs is unknown. To examine the require-
ment for XRCC1 interaction with Lig3 during DNA ligation, we
employed XRCC1 mutant EM9 CHO cells stably expressing ei-
ther wild-type recombinant human XRCC1-His (EM9-XH
cells), XRCC1-His529-633 protein lacking the C-terminal
BRCT domain that binds Lig3 (EM9-XH529-633 cells), or an
empty expression vector (EM9-V cells) (Fig. 1B). We have
shown previously that the deletion of the C-terminal BRCT
domain ablates binding to Lig3 (36). Consistent with this,
Lig3 levels were no higher in EM9-XH529-633 cells than in
EM9-V cells, consistent with the requirement for interaction
with XRCC1 for Lig3 stability (Fig. 1B) (11, 12). Notably,
while EM9-V cells harboring empty vector were hypersensitive
to H2O2-induced oxidative stress, the level of sensitivity of
EM9-XH529-633 cells to H2O2 was similar to that of EM9-XH
(Fig. 1C). To measure chromosomal SSBR rates, we employed
alkaline comet assays. Although this assay can detect both
SSBs and DSBs, the vast majority (	99%) of breaks induced
by H2O2 are SSBs (4). Surprisingly, while EM9-V cells harbor-
ing empty vector exhibited reduced rates of global SSBR fol-
lowing H2O2-induced oxidative stress, SSBR rates in EM9-
XH529-633 cells were similar to those of EM9-XH (Fig. 1D).
We conclude that the interaction between XRCC1 and Lig3
is dispensable for the repair of oxidative SSBs in proliferating
CHO cells.
To examine the requirement for XRCC1 interaction with
DNA Pol , we employed EM9 cells expressing XRCC1 pro-
tein harboring the point mutation F67A (Fig. 2A). This muta-
tion is located within the N-terminal domain (NTD) that binds
Pol  and reduces the interaction of XRCC1 with the DNA
polymerase in vitro (33). Consistent with this, the F67A mu-
tation reduced Pol  binding by XRCC1 more than 25-fold in
vivo, whereas the interaction with aprataxin (APTX), which is
mediated by the C-terminal half of XRCC1, was only weakly
(
2-fold) affected (data not shown; also see Fig. S1A in the
supplemental material). In addition, whereas Pol  copurified
with XRCC1-His from EM9-XH cell extract, it failed to do so
measurably from cell extract from EM9 cells expressing
XRCC1-HisF67A (denoted EM9-XHF67A cells) (see Fig. S1B in
the supplemental material). XRCC1-HisF67A largely corrected
the hypersensitivity of XRCC1-deficient EM9 cells to H2O2,
suggesting that the XRCC1-Pol  interaction is dispensable for
cell survival following oxidative DNA damage (Fig. 2B).
XRCC1-HisF67A similarly restored cellular resistance to H2O2
in EM-C11 cells, a second XRCC1 mutant CHO cell line (see
Fig. S2 in the supplemental material). XRCC1-HisF67A also
complemented the defect in chromosomal SSBR rates in
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XRCC1 mutant cells, because H2O2-induced DNA breaks de-
clined at normal rates in EM9-XHF67A cells compared to those
of EM9-V cells (Fig. 2C). This result was not limited to H2O2-
induced oxidative stress, because similar results were observed
following ionizing radiation (Fig. 2D). Notably, in contrast to
oxidative stress, XRCC1-HisF67A failed to fully correct cellular
hypersensitivity and reduced repair rates in EM9 cells follow-
ing methyl methanesulfonate (MMS) treatment, consistently
with the established importance of the XRCC1-Pol  interac-
tion during DNA base excision repair (BER) (15, 38, 56) (Fig.
2E and F). We conclude that while the XRCC1-Pol  interac-
tion is required for efficient BER, it is dispensable for cell
survival and rapid rates of chromosomal SSBR in proliferating
cells following oxidative stress.
To confirm that the requirement for XRCC1 for rapid rates
of SSBR in asynchronous CHO cells did not require interac-
FIG. 1. XRCC1-DNA ligase III interaction is dispensable for rapid SSBR rates following oxidative stress in proliferating CHO cells.
(A) Schematic depicting human XRCC1 and the protein domains that mediate interaction with Pol , PNK, APTX, and Lig3. Asterisks denote
the three clusters of consensus CK2 phosphorylation sites. (B) Cell extracts from the indicated cell lines were fractionated by SDS-PAGE,
transferred to nitrocellulose, and immunoblotted with anti-XRCC1 monoclonal, anti-Lig3 polyclonal, anti-Pol  polyclonal, or anti--actin
monoclonal antibody. (C) Clonogenic sensitivity of the indicated EM9 CHO cell lines to H2O2. Cells were treated for 15 min at room temperature
with the indicated concentrations of H2O2 in PBS, and surviving colonies were stained and counted after 10 to 14 days. Data are the means (
standard errors of the means) of at least three independent experiments. (D) DNA strand break repair rates following H2O2 treatment as measured
by alkaline comet assays. The indicated EM9 CHO cell lines were treated with 150 M H2O2 for 20 min on ice in PBS and then incubated for the
indicated repair periods in drug-free media. DNA strand breaks were quantified by alkaline comet assays from three or more independent
experiments. (Left) Mean tail moments were quantified from 100 cells/sample/experiment and are the averages ( standard errors of the means)
of at least three independent experiments. (Right) The data in the left panel were plotted as the mean fractions of DNA strand breaks remaining
at the indicated time points.
VOL. 29, 2009 3-PHOSPHATASE ACTIVITY AND GLOBAL RATES OF SSBR 4655
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tion with either Pol  or Lig3, we employed a truncated
derivative of human XRCC1 (His-XRCC1161-533) lacking both
the amino-terminal (NTD) and C-terminal domains that bind
Pol  and Lig3, respectively (Fig. 3A). This protein mimics
the native XRCC1 homolog that is present in the plant Arabi-
dopsis thaliana, and it was expressed in EM9 cells at levels
similar to those of wild-type human His-XRCC1 (Fig. 3B).
Notably, proliferating EM9-HX161-533 cells expressing the
truncated protein exhibited both normal sensitivity (Fig. 3C)
and normal rates of SSBR following H2O2 treatment (Fig. 3D
and E). These data identify the region spanning amino acids
161 to 533 as sufficient for the ability of XRCC1 to maintain
cell survival and rapid global rates of SSBR in proliferating
CHO cells.
Residues 161 to 533 encompass the most evolutionarily con-
served region of XRCC1 and include the inter-BRCT domain
linker region of 100 amino acids (Fig. 3A). This region,
which is phosphorylated multiple times at CK2 consensus sites
that are grouped into three clusters at residues 408/409/410,
485/488, and 518/519/523, mediates phosphorylation-specific
interactions with the DNA end-processing factors PNK (30)
and APTX (13, 31) and also with a recently identified protein
of unknown function, denoted APLF (2, 22, 24). Previously, we
mutated all eight of the predicted primary CK2 phosphoryla-
tion sites in XRCC1 and showed that the mutant protein (de-
noted XRCC1CKM) was unable to support normal rates of
SSBR following oxidative stress (30). However, whether the
importance of this region for SSBR reflects the interaction
with PNK or with APTX and/or APLF is unknown. To address
this issue, we mapped the site of PNK interaction in detail by
mutating each of the three clusters of CK2 phosphorylation
sites separately and expressing the respective proteins, denoted
XRCC1-HisS408A/S409A/S410A, XRCC1-HisS485A/T488A, and
XRCC1-HisS518A/T519A/T523A, in EM9 cells (Fig. 4A). PNK
FIG. 2. XRCC1-Pol  interaction is dispensable for rapid SSBR rates following oxidative stress in proliferating CHO cells. (A) Cell extracts
from the indicated cell lines were fractionated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with anti-XRCC1 monoclonal,
anti-Lig3 polyclonal, anti-Pol  polyclonal, or anti--actin monoclonal antibody. (B) Clonogenic sensitivity of the indicated cell lines to H2O2. Cells
were treated for 15 min at room temperature with the indicated concentrations of H2O2 in PBS, and surviving colonies were stained and counted
after 10 to 14 days. Data are the means ( standard errors of the means) of at least three independent experiments. (C) DNA strand break repair
rates following H2O2 treatment. The indicated CHO cell lines (symbols as in panel B) were treated with 200 M H2O2 for 10 min on ice and then
incubated for the indicated repair periods in drug-free media. DNA strand breaks were quantified by alkaline comet assays as described in the
legend to Fig. 1. Mean tail moments were quantified from 100 cells/sample/experiment and are the averages ( standard errors of the means)
of at least three independent experiments. (D) DNA strand break repair rates following gamma radiation. The indicated CHO cell lines (symbols
as in panel B) were treated with irradiation (IR) (20 Gy) and then incubated for the indicated repair periods in drug-free media. DNA strand
breaks were quantified as described for panel C. (E) Clonogenic sensitivity of the indicated cell lines to MMS. Cells were treated for 15 min at
37°C with the indicated concentrations of MMS, and surviving colonies stained and counted after 10 to 14 days. Data are the means ( standard
errors of the means) of at least three independent experiments. (F) DNA strand break repair rates following MMS treatment. The indicated CHO
cell lines (symbols as in panel B) were treated with the indicated concentrations of MMS for 15 min at 37°C, and the accumulated levels of DNA
strand breaks were quantified as described for panel C.
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copurified with wild-type XRCC1-His, XRCC1-His
S408A/S409A/S410A
,
and XRCC1-HisS485A/T488A during affinity chromatography
but failed to copurify with either XRCC1-HisCKM or XRCC1-
HisS518A/T519A/T523A (Fig. 4B). Most of the recombinant
XRCC1 recovered in these experiments was truncated by 10
kDa due to the proteolytic removal of the labile amino-termi-
nal domain. This did not affect interaction with PNK, however,
which occurs toward the C terminus of XRCC1. We conclude
FIG. 3. His-XRCC1161-533 restores cellular resistance and rapid SSBR rates in XRCC1 mutant CHO cells following oxidative stress. (A) Sche-
matic depicting the evolutionarily conserved domains in XRCC1. XRCC1 homologues in Homo sapiens, Drosophila melanogaster, and Arabidopsis
thaliana are shown, along with the truncated derivative of human XRCC1 employed here (denoted His-XRCC1161-533). Asterisks denote clusters
of CK2 consensus phosphorylation sites. (B) XRCC1 protein levels in XRCC1 mutant CHO cells stably transfected with empty expression vector
(EM9-V) or with expression constructs encoding either wild-type His-XRCC1 (EM9-HX) or mutant His-XRCC1 lacking the NTD and C-terminal
BRCT II domain (EM9-HX161-533). Cell extracts from the indicated cell lines were fractionated by SDS-PAGE, transferred to nitrocellulose, and
immunoblotted with anti-XRCC1 monoclonal, anti-Lig3 polyclonal, anti-Pol  polyclonal, or anti--actin monoclonal antibody. (C) Clonogenic
sensitivity of the indicated cell lines to H2O2. Cells were treated for 15 min at room temperature with the indicated concentrations of H2O2 in PBS,
and surviving colonies were stained and counted after 10 to 14 days. Data are the means ( standard errors of the means) of at least three
independent experiments. (D) DNA strand break repair rates following H2O2 treatment as measured by alkaline comet assays. The indicated CHO
cell lines were treated with 150 M H2O2 for 20 min on ice and then incubated for the indicated repair periods in drug-free media. DNA strand
breaks were quantified by alkaline comet assays as described in the legend to Fig. 1. (Left) Mean tail moments were quantified from 100
cells/sample/experiment and are the averages ( standard errors of the means) of at least three independent experiments. (Right) The data in the
left panel were plotted as the mean fractions of DNA strand breaks remaining at the indicated time points.
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from these experiments that the interaction between XRCC1
and PNK requires only the cluster of CK2 phosphorylation
sites at S518/T519/T523. Notably, this is the same cluster of
CK2 phosphorylation sites that interacts with APTX (31).
None of the CK2 phosphorylation site mutations greatly
affected the ability of XRCC1 to correct the hypersensitivity
of EM9 cells to H2O2 (Fig. 4C). In contrast, global rates
of SSBR were markedly slower in EM9-XHCKM and
EM9-XHS518A/T519A/T523A cells than in EM9-XH, EM9-
XHS408A/S409A/S410A, or EM9-XHS485A/T488A cells (Fig. 5A).
This suggests that, of the three clusters of CK2 phos-
phorylation sites, only S518/T519/T523 is required for the
rapid repair of oxidative SSBs. Although APTX also binds this
region of XRCC1, we considered it more likely that the re-
duced SSBR rate in EM9-XHS518A/T519A/T523A cells resulted
from the loss of PNK interaction. This is because, in our hands,
the loss of APTX activity by itself does not affect global rates
of SSBR following oxidative stress (17, 43), whereas the loss of
PNK has been reported to slow the rate of the repair of oxi-
dative SSBs (41). To examine directly whether the mutation of
S518/T519/T523 slowed chromosomal SSBR rates by disrupting
the XRCC1-PNK interaction, we examined whether normal rates
of SSBR could be restored in EM9-XHS518A/T519A/T523A cells by
PNK overexpression (Fig. 5B). Indeed, the rate of chromo-
somal SSBR observed in EM9-XHS518A/T519A/T523A cells was
restored to normal by the transient overexpression of wild-type
recombinant human PNK protein (Fig. 5C). In contrast,
PNKD171N, harboring a mutated DNA 3-phosphatase domain,
was unable to complement the defect in SSBR in EM9-
XHS518A/T519A/T523A cells. These data demonstrate, for the
first time, that DNA 3-phosphatase activity is critical for rapid
global rates of chromosomal SSBR following oxidative stress,
and they suggest that the XRCC1-PNK interaction ensures
that this activity does not become rate limiting in vivo.
DISCUSSION
XRCC1 is a critical component of the SSBR machinery and
functions as a molecular scaffold that interacts with multiple
enzymatic components of the repair process (9). While numer-
ous XRCC1 partners and their respective binding sites have
been identified, it is unclear which of these interactions is
important for rapid SSBR rates following oxidative stress in
vivo. An understanding of the protein-protein interactions me-
diated by XRCC1 and their importance during oxidative stress
is likely to affect our understanding of human disease, because
oxidative stress is a major source of SSBs. Indeed, mutations in
components of the SSBR machinery have been identified in
FIG. 4. Mutation of the cluster of CK2 phosphorylation sites at S518/T519/T523 greatly reduces or ablates interaction with PNK. (A) Total cell
extracts from 5  104 of cells expressing the indicated recombinant XRCC3 protein or harboring empty vector (v) were fractionated by
SDS-PAGE, transferred to nitrocellulose, and immunostained with anti-XRCC1 polyclonal antibody or anti--actin monoclonal antibody.
(B) XRCC1-His protein complexes were recovered from whole-cell extract from 5  106 of the indicated cells by affinity chromatography as
described in Materials and Methods. Aliquots of the column input (8% of column input), flowthrough, and 250 mM imidazole eluate (13% of total
eluate) were fractionated by SDS-PAGE and immunoblotted for the presence of anti-XRCC1 (XRCC1) or anti-PNK (PNK) polyclonal
antibody. (C) Clonogenic sensitivity of the indicated cell lines to H2O2. Cells were treated for 15 min at room temperature with the indicated
concentrations of H2O2 in PBS, and surviving colonies were stained and counted after 10 to 14 days. Data are the means of at least three
independent experiments ( standard errors of the means).
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two hereditary neurodegenerative diseases (recently reviewed
in references 9 and 42).
Notably, the XRCC1 mutation F67A failed to prevent
XRCC1 from restoring cellular resistance and normal SSBR
rates in proliferating EM9 cells following H2O2 treatment or
ionizing radiation, despite reducing the interaction with Pol 
more than 26-fold. It is unlikely that this reflects residual levels
of interaction, because this mutation results in cellular hyper-
FIG. 5. PNK overexpression overrides the requirement for S518/T519/T523 for rapid global rates of chromosomal SSBR following oxidative stress.
(A) DNA strand break repair rates following H2O2 treatment as measured by alkaline comet assays. The indicated EM9 CHO cell lines were treated with
150 M H2O2 for 20 min on ice in PBS and then incubated for the indicated repair periods in drug-free media. DNA strand breaks were quantified by
alkaline comet assays as described in the legend to Fig. 1. Mean tail moments were quantified from 100 cells/sample/experiment and are the averages
( standard errors of the means) of at least three independent experiments. V, EM9 cells harboring empty vector. (B) Total cell extracts from 3  104
EM9-XH (XH) or EM9-V (v) cells or EM9-XHS518A,T519A,T523A cells transiently transfected with empty vector or with the indicated PNK expression
construct were fractionated by SDS-PAGE, transferred to nitrocellulose, and immunostained with anti-PNK polyclonal, anti-XRCC1 monoclonal, or
anti--actin monoclonal antibody. (C) DNA strand break repair rates following H2O2 treatment as measured by alkaline comet assays. The CHO cells
described for panel B were mock treated (H2O2) or treated with 150 M H2O2 (H2O2) for 20 min on ice (left) and then incubated for the indicated
repair periods in drug-free medium (right). DNA strand breaks were quantified by alkaline comet assays as described above. The data are plotted as the
mean fraction of DNA strand breaks remaining and are the averages of at least three independent experiments ( standard errors of the means).
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sensitivity and reduced SSBR rates following treatment with
MMS, which is consistent with the established requirement for
this interaction during BER at sites of DNA alkylation (15, 38,
56). Also, His-XRCC1161-533 protein fully restored rapid global
SSBR rates in EM9 cells following H2O2 despite the complete
absence of the Pol  binding N-terminal domain in this pro-
tein. We conclude from these data that Pol  can function
independently of interaction with XRCC1 following oxidative
DNA damage or, more likely, that another DNA polymerase
can substitute for Pol . For example, Pol , Pol , and Pol Q
also are implicated in the cellular response to H2O2, and Pol Q
has been reported to physically associate with XRCC1 (5, 39,
47, 51, 57). Alternatively, the long-patch repair DNA poly-
merases Pol  and/or Pol ε might substitute for Pol . Consis-
tent with this idea, while early-passage and proliferating pop-
ulations of Pol / murine embryonic fibroblasts exhibit
normal sensitivity and DNA strand break repair rates following
oxidative stress, increased sensitivity and decreased repair
rates are observed in late-passage or G1-enriched Pol 
/
murine embryonic fibroblasts, conditions under which long-
patch repair machinery may be downregulated (21, 52, 53). It
remains to be determined whether a similar cell cycle stage-
specific requirement exists for the interaction of Pol  with
XRCC1.
Surprisingly, the deletion of the entire XRCC1 C-terminal
BRCT domain (BRCT II) that binds Lig3 also failed to sig-
nificantly affect global SSBR rates in asynchronous CHO cells
following oxidative stress. Once again, it is unlikely that this
reflects residual interaction between XRCC1 and Lig3. This
is because interaction with XRCC1 is required to stabilize the
DNA ligase in vivo, yet the cellular level of Lig3 is no higher
in EM9-XH529-633 cells expressing XRCC1 that lack the
BRCT II domain than in EM9 cells that lack XRCC1 alto-
gether (36). Consequently, either Lig3 can function indepen-
dently of XRCC1 following oxidative stress or, more likely,
another DNA ligase can substitute for Lig3 in proliferating
CHO cells. One possibility is that Lig1 can fulfill this role,
because this DNA ligase is associated with the DNA replica-
tion machinery and can conduct BER in vitro (29, 35, 40). It
will be of interest to examine whether the requirement for
XRCC1-Lig3 interaction during SSBR following oxidative
stress exhibits cell cycle specificity, as has been reported for
this interaction following ethyl methanesulfonate-induced
DNA alkylation (36, 48).
The phosphorylation of XRCC1 by CK2 within a 100-amino-
acid region linking the internal (BRCT I) and C-terminal (BRCT
II) BRCT domains is required both for PNK interaction and for
rapid SSBR rates following H2O2 treatment (30). However, the
phosphorylation of this linker region by CK2 also facilitates in-
teractions with the DNA repair proteins APTX and APLF, con-
fusing the issue of which interaction(s) accounts for the impor-
tance of this region for rapid SSBR (2, 13, 22, 31). To address this
question, we mapped in detail the PNK binding site within the
linker region and identified the cluster of CK2 phosphorylation
sites in XRCC1 located at S518, T519, and T523 as being critical
for this purpose. Intriguingly, S518/T519/T523 is also the APTX
binding site, providing an explanation for the observation that
XRCC1 associates with these proteins in separate and distinct
complexes (31). The mutation of S518/T519/T523 reduced SSBR
rates to a level similar to that observed if all eight primary CK2
sites within the linker region were mutated. In contrast, mutation
of the remaining CK2 sites by themselves failed to slow SSBR.
The CK2 phosphorylation of XRCC1 within the inter-BRCT
domain linker region thus accelerates SSBR largely or entirely via
S518/T519/T523.
Although S518/T519/T523 mediates interactions with multi-
ple proteins, we considered it likely that it is the PNK inter-
action that accounts for the importance of these residues for
rapid SSBR following H2O2 treatment. This is because a large
fraction (	50%) of the breaks induced by oxidative stress are
believed to possess 3-phosphate termini, and thus are putative
substrates for the 3-phosphatase activity of PNK. In addition,
so far we have failed to detect an impact of the loss of APTX
or APLF alone on rapid global rates of SSBR in proliferating
mammalian cells (data not shown). Consistent with this find-
ing, the overexpression of wild-type PNK restored normal rates
of SSBR in CHO cells expressing XRCC1-HisS518/T519/T523
following H2O2 treatment, confirming that the requirement for
S518/T519/T523 for rapid global SSBR rates reflects the inter-
action of this region with PNK. Why might the interaction
between XRCC1 and PNK be important for rapid chromo-
somal SSBR rates following oxidative stress? One possibility is
that interaction with XRCC1 ensures that PNK activity is not
rate limiting during SSBR in vivo. This idea is consistent with
the observation that XRCC1 stimulates PNK activity in vitro at
limiting concentrations of the latter enzyme, possibly by disso-
ciating PNK from its DNA product and thereby increasing the
enzyme turnover rate (32, 54). However, interaction with
XRCC1 also might promote the recruitment or accumulation
of PNK at chromosomal SSBs, because the appearance of this
protein in subnuclear foci is reduced in EM9-XHCKM cells
following oxidative stress (30).
Human PNK possesses both 5-DNA kinase and 3-DNA
phosphatase activities (23, 25). Whereas 5-hydroxyl termini
likely are present at only a minor fraction of DNA strand
breaks following oxidative DNA damage, 3-phosphate termini
may be present at 70% or more of all such breaks (20). Con-
sistent with this, the overexpression of PNK harboring a mu-
tated 3-phosphatase domain failed to complement the SSBR
defect in EM9-XHS518A/T519A/T523A cells. Although the muta-
tion of D171 does not directly affect the DNA kinase activity of
PNK, it is possible that the repair of 5-hydroxyl termini also is
inhibited by the mutation of the 3-phosphatase domain. This is
because the persistence of a 3-phosphate terminus may inhibit
the phosphorylation of an adjacent 5-hydroxyl terminus (16).
Nevertheless, the inability of PNKD171N to restore rapid SSBR
rates demonstrates directly that 3-DNA phosphatase activity
is crucial for rapid rates of SSBR following oxidative stress.
Interestingly, the overexpression of AP endonuclease-1
(APE1), another protein that can process damaged 3 termini,
also increases chromosomal SSBR rates in XRCC1 mutant
cells following oxidative stress, albeit to less than half the rate
present in wild-type cells (45). However, the 3-phosphatase
activity of human APE1 is two to three orders of magnitude
less than that of PNK and is unlikely to be a physiologically
relevant source of 3-DNA phosphatase activity in vivo (55).
Indeed, the impact of mutating XRCC1 at S518A/T519A/
T523A on both PNK binding and chromosomal SSBR rates
strongly suggests that PNK, in conjunction with XRCC1, is the
major source of this activity in vivo.
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In summary, we demonstrate here for the first time that
there is a critical requirement for DNA 3-phosphatase activity
during the repair of chromosomal SSBs following oxidative
stress, and we suggest that the XRCC1 interaction with PNK
ensures that this activity is not rate limiting in vivo.
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